STAT

MARCH 21, 2023

government to remove the key negotiator working on a free trade agreement with the Indian government because of his previous ties to a major pharmaceutical company. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.

Generic Medicine

European Pharmaceutical Review

MARCH 14, 2023

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects. He has been advising pharmaceutical companies and healthcare providers for a number of years.

Packaging

Pharmaceutical Technology

DECEMBER 19, 2022

This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceutical companies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.

Pharmaceutical Companies

European Pharmaceutical Review

FEBRUARY 2, 2023

This left pharmaceutical companies in Europe with no European API supply source, and only a few suppliers in Asia. A recent example was the sudden shortage of the API tamoxifen, used in a key breast cancer therapy, as the only European API manufacturer halted production because it had become uneconomical.

Generic Medicine

The Guardian - Pharmaceutical Industry

FEBRUARY 7, 2024

Britain is pushing for patent changes that could increase the cost of Indian generic drugs, diverting more of the NHS budget to big pharma India is known as the “ pharmacy of the world ”, supplying vital generic medicines at low prices to health services including the NHS. They spend billions on research and recoup billions.

Generic Medicine

pharmaphorum

DECEMBER 15, 2020

During this time, the role and responsibility of generics suppliers and manufacturers has been brought into stark perspective as one of the leading contributors in this industry-wide effort. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies.

Generic Medicine

pharmaphorum

AUGUST 25, 2022

The new partnership “marks a major milestone in Sonde Health’s growth and evolution,” according to the company’s chief executive David Liu.

Generic Medicine

STAT

SEPTEMBER 27, 2024

It is a new type of medicine that works by stimulating a pair of muscarinic receptors in the brain, that, in turn, control the release of a brain chemical called acetylcholine. Current antipsychotics, which include generic medicines and branded products,  mostly regulate mood by blocking dopamine receptors.

Generic Medicine

European Pharmaceutical Review

FEBRUARY 26, 2024

Medicine indication extensions recommended by the CHMP The committee recommended extensions of indications for six EU-approved medicines, including: CARVYKTI ® ▼ (ciltacabtagene autoleucel; cilta-cel)* , Keytruda and Reblozyl*. These products were designated as an orphan medicine during their development.

Generic Medicine

The Checkup by Singlecare

FEBRUARY 10, 2025

While brand-name drugs like Farxiga can be costly, people often want to know: When will a cost-saving generic be available? Is there a generic for Farxiga ? The pharmaceutical company Prasco currently markets a generic version of Farxiga.

Dosage

PharmTech

JULY 25, 2025

*full transcript below In Part 4 of our multi-part interview series, Jason Waite, an international trade expert at Alston & Bird, underscores the urgent need for pharmaceutical companies to build cross-functional trade compliance teams in response to rising global trade tensions—particularly potential Section 232 tariffs.

Dosage

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging

European Pharmaceutical Review

FEBRUARY 20, 2025

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.

Generic Medicine